MarketPeel
Insider Trading Intelligence
Pricing
…
PS

Peter Svennilson

ORIC
DIRECTOR · ORIC PHARMACEUTICALS, INC. · CIK 0001606074
FILING MIX · LIFETIME51%/49%
BUYS
64
SELLS
61
TOTAL VALUE
$143.53M
COMPANIES
7
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
6,400,729
AVG SELL PX
$7.73
TRADE KIND
SHOWING 125 / 125
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
45 backtested trades · 8 horizons · 57 pending
Forward-return performance of every backtestable P/S trade by Peter Svennilson, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d45+86.67%-5.36%+0.46%-5.82%-6.91%-2.93
14d45+77.78%+7.44%+0.41%+7.03%+2.79%1.82
30d45+68.89%+4.41%-1.29%+5.71%+16.80%1.22
60d45+66.67%+5.38%+1.10%+4.28%-2.14%0.75
90d45+62.22%+19.30%+5.34%+11.80%-22.63%1.28
180d45(19 pending)+100.00%-7.95%+5.80%-13.75%-41.53%—
1y45(19 pending)+100.00%-9.37%+9.06%-18.43%-52.32%—
2y45(19 pending)+69.23%-53.99%+13.89%-67.88%-59.93%—
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORIC · 3,568,181 shares · as of Nov 16, 2021
01,192,0452,384,0913,576,1364,768,1812021SHARES HELD
Trading cadence · quarterly flow
BUY ● SELL ●
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 64 buys / 61 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,649,281$0.56$927.6K0Feb 25, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,862,545$0.56$1.05M0Feb 25, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
309,228$0.62$190.3K1,649,281Feb 24, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
349,212$0.62$214.9K1,862,545Feb 24, 2026Feb 26, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
143,709$0.60$85.8K1,958,509Feb 23, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
162,291$0.60$96.9K2,211,757Feb 23, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
245,965$0.61$151.2K2,102,218Feb 20, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
277,769$0.61$170.8K2,374,048Feb 20, 2026Feb 24, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
1,905,115$0.68$1.30M2,348,183Feb 11, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
2,151,458$0.68$1.46M2,651,817Feb 11, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
161,422$0.82$131.7K4,253,298Feb 10, 2026Feb 12, 2026 ↗View →
TNYA
TENAYA THERAPEUTICS, INC.
SALE
182,295$0.82$148.8K4,803,275Feb 10, 2026Feb 12, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
49,556$18.00$892.0K148,840Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
827,278——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,403,568——2,763,888Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
5,133,076——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,437,323$18.00$25.87M4,312,139Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
1,296,629——1,360,320Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
688,283——688,283Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
10,467,526——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
110,928——2,874,816Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
28,229——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
9,670,000——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
330,000——0Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
47,898——95,499Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
44,249——47,601Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
630,881$18.00$11.36M1,319,164Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
PURCHASE
3,785——99,284Feb 6, 2026Feb 9, 2026 ↗View →
EIKN
EIKON THERAPEUTICS, INC.
SALE
357,216——0Feb 6, 2026Feb 9, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
8,484$19.60$166.3K900,292Jan 20, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
9,568$19.60$187.5K1,016,658Jan 20, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
1,358$20.00$27.2K1,007,090Jan 16, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
1,204$20.00$24.1K891,808Jan 16, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
6,303$19.89$125.4K1,005,732Jan 15, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
5,590$19.89$111.2K890,604Jan 15, 2026Jan 20, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,927$19.99$58.5K999,429Jan 14, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
2,596$19.99$51.9K885,014Jan 14, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
6,609$19.80$130.9K996,502Jan 13, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
5,861$19.80$116.1K882,418Jan 13, 2026Jan 15, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
7,097$19.89$141.1K876,557Jan 6, 2026Jan 8, 2026 ↗View →
SRZN
SURROZEN, INC./DE
PURCHASE
8,003$19.89$159.2K989,893Jan 6, 2026Jan 8, 2026 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,599,417——1,599,417Dec 23, 2024Dec 23, 2024 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,352,008——1,352,008Dec 23, 2024Dec 23, 2024 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
SALE
1,352,008——50,000Dec 23, 2024Dec 23, 2024 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
SALE
1,599,417——0Dec 23, 2024Dec 23, 2024 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,837$12.45$22.9K1,236,261May 25, 2022May 27, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
63$12.45$78542,189May 25, 2022May 27, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
538$12.00$6.5K42,126May 24, 2022May 25, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
15,776$12.00$189.3K1,234,424May 24, 2022May 25, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
9,898$12.50$123.7K1,218,648May 23, 2022May 25, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
338$12.50$4.2K41,588May 23, 2022May 25, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
1,208,750$10.67$12.90M1,208,750May 10, 2022May 12, 2022 ↗View →
RAPT
RAPT THERAPEUTICS, INC.
PURCHASE
41,250$10.67$440.2K41,250May 10, 2022May 12, 2022 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
86,716——103,341Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
74——74Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
287,702——287,702Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
86,716——86,716Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
287,702——0Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
1,200,000——3,568,181Nov 16, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
16,625——0Nov 12, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
16,625$16.00$266.0K16,625Nov 12, 2021Nov 16, 2021 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,625——16,625Jun 16, 2021Jun 17, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
17,829——134,010May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
49,689——0May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
1,000,000——989,000May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
17,829——139,383May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
438,338——0May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
49,689——49,689May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
10,307——10,307May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
2,000,000——1,394,333May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
105,874——116,181May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
111,247——121,554May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
438,338——438,338May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
7,752——48,406May 5, 2021May 7, 2021 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
30,347——40,654May 5, 2021May 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
47$42.50$2.0K1,571,963Apr 28, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
53$42.50$2.3K1,775,236Apr 28, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
12,371$42.65$527.7K1,775,289Apr 27, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
10,955$42.65$467.3K1,572,010Apr 27, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
24,883$42.85$1.07M1,582,965Apr 26, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
28,101$42.85$1.20M1,787,660Apr 26, 2021Apr 28, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
11,600$43.83$508.4K1,607,848Apr 9, 2021Apr 12, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
13,101$43.83$574.2K1,815,761Apr 9, 2021Apr 12, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
21,710$44.80$972.7K1,619,448Apr 8, 2021Apr 12, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
24,518$44.80$1.10M1,828,862Apr 8, 2021Apr 12, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
14,825$45.60$676.1K1,853,380Apr 7, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
13,128$45.60$598.7K1,641,158Apr 7, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
18,551$48.06$891.6K1,654,286Apr 6, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
20,949$48.06$1.01M1,868,205Apr 6, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
9,661$46.65$450.7K1,889,154Apr 5, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
8,554$46.65$399.1K1,672,837Apr 5, 2021Apr 7, 2021 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
530,365——1,898,815Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
13,068——20,302Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
469,635——1,681,391Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
46,868——0Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
22,011——22,011Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
24,857——46,868Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
46——46Dec 9, 2020Dec 11, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
952,023$36.40$34.65M2,151,026Nov 16, 2020Nov 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
1,075,133$36.40$39.13M2,429,180Nov 16, 2020Nov 18, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
600,000——0Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
1,989,000——1,989,000Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
1,989,000——0Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
1,836,000——0Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
1,836,000——3,394,333Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
686,274——0Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
875,000——1,558,333Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
SALE
875,000——0Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
600,000——683,333Jul 28, 2020Jul 29, 2020 ↗View →
NRIX
NURIX THERAPEUTICS, INC.
PURCHASE
686,274——686,274Jul 28, 2020Jul 29, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
25,318——25,318Jun 17, 2020Jun 19, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASEGRANT
Stock grant
7,234——7,234Jun 17, 2020Jun 19, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
3,500,000——0Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
625,000——4,200,000Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
151,515——0Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
3,500,000——3,575,000Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
416,666——4,616,666Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
416,666——0Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASE
151,515——4,768,181Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
SALE
625,000——0Apr 28, 2020Apr 28, 2020 ↗View →
ORIC
ORIC PHARMACEUTICALS, INC.
PURCHASEGRANT
Stock grant
16,625——16,625Apr 23, 2020Apr 27, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
PURCHASE
7,977,384——7,977,384Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
99,758——0Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
5,137,583——0Feb 18, 2020Feb 18, 2020 ↗View →
RVMD
REVOLUTION MEDICINES, INC.
SALE
2,740,043——0Feb 18, 2020Feb 18, 2020 ↗View →
Other insiders · ORIC
Loading peer insiders…
About this filer
CIK 0001606074
ROLE
Director
PRIMARY
ORIC
COMPANIES
7
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001606074DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

The morning brief, before the bell.

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback